Skip to main content
. 2019 May 2;17:40. doi: 10.1186/s12964-019-0352-4

Fig. 1.

Fig. 1

Retinoids used in the study grouped into those that are RAR agonists, RXR agonists, RAR antagonists, poor RAR agonists and antagonists for RBP4